InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Poulton Stuart, Directeur du Développement. Insider active across 1 company, notably Karyopharm Therapeutics Inc.. Cumulatively, 2 filings have been recorded. History available since 13 May 2026. The latest transaction was disclosed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
896 shares0Common StockSEC:0001193125-26-226697:0
896 shares0Common StockSEC:0001193125-26-226697
2 of 2 declarations
About Poulton Stuart
Poulton Stuart is the Chief Development Officer at Karyopharm Therapeutics Inc. He is responsible for developing and implementing product development strategies. His expertise is crucial for the success of the company's research and development initiatives.
